Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

4 clinical studies listed.

Filters:

Keratosis, Actinic

Tundra lists 4 Keratosis, Actinic clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

COMPLETED

NCT06135415

A Study to Evaluate the Efficacy and Safety of Tirbanibulin Ointment in Adult Participants With Actinic Keratosis

The purpose of the study is to evaluate the efficacy and safety of tirbanibulin 10 milligrams per gram (mg/g) ointment when applied to a treatment field (TF) larger than 25 square centimeters (cm\^2) and up to 100 cm\^2 in adult participants with actinic keratosis (AK).

Gender: All

Ages: 18 Years - Any

Updated: 2026-06-30

Keratosis, Actinic
COMPLETED

NCT03076918

Evaluating the Device FLEXITHERALIGHT Compared to the Conventional Photodynamic Therapy

This study compares the efficacy and tolerance of a new device (FLEXITHERALIGHT) for photodynamic therapy in the treatment of keratosis actinic in comparison of classical PDT with Aktilite®.

Gender: All

Ages: 18 Years - Any

Updated: 2026-04-21

Keratosis, Actinic
ACTIVE NOT RECRUITING

NCT05387525

A Study of Tirbanibulin Ointment and Diclofenac Sodium Gel for the Treatment of Adult Participants With Actinic Keratosis on the Face or Scalp

The purpose of the study is to evaluate the incidence of biopsy confirmed invasive squamous cell carcinoma (SCC) in the selected treatment field (TF) after administration of topical tirbanibulin 10 milligram (mg)/gram (g) ointment or diclofenac sodium 3 percent (%) gel over the 3-year study period.

Gender: All

Ages: 18 Years - Any

Updated: 2025-02-11

Keratosis, Actinic
ACTIVE NOT RECRUITING

NCT05636800

Microwave Treatment for Actinic Keratosis

This is a randomized, controlled, multi-center trial in subjects diagnosed with Actinic Keratosis (AK) where each subject serves as their own control. The trial will be conducted at 2 sites, one in Germany and one in the United States. Approximately 60 subjects will be randomized to ensure 51 subjects complete the study.

Gender: All

Ages: 18 Years - 85 Years

Updated: 2024-08-06

1 state

Keratosis, Actinic